Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development
Go back to Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development| Aurum Resources Corp (NYSE: ARMP) | Delayed: 3.06 -0.14 (4.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.20 | 52 Week High | $2.00 | |||
| Open | $3.21 | 52 Week Low | $1.50 | |||
| Day High | $3.21 | P/E | N/A | |||
| Day Low | $2.97 | EPS | $0.00 | |||
| Volume | 18,302 | |||||



